MedPath

To Compare Intravenous and Oral Hydration of the Prevention for CIN in Elderly Patients Undergoing Intravenous CECT

Not Applicable
Conditions
CIN
Registration Number
NCT03872739
Lead Sponsor
Yu Danqing
Brief Summary

To Compare Intravenous and Oral Hydration of the Prevention for Contrast-induced Nephropathy in Elderly Patients Undergoing Intravenous Contrast-enhanced Computed Tomography.

Detailed Description

The prospective multicenter randomized controlled clinical research discusses the comparison of oral and intravenous hydration for prevention of contrast-induced nephropathy in elderly patients with enhanced computed tomography, establishing a simple hydration proposal.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
1368
Inclusion Criteria
  • Age>21
  • informed consent
  • Undergoing Intravenous Contrast-enhanced Computed Tomography
Exclusion Criteria
  • CT enhancement was not performed;
  • Dialysis treatment of patients with end-stage renal failure or heart, kidney transplantation;
  • Exposure to radioactive contrast medium within 48 hours prior to or within 72 hours of examination;
  • Acute decompensated heart failure;
  • Allergic to radioactive contrast agent;
  • Be subjected to life - threatening trauma;
  • Severe infection;
  • Surgery was performed within 2 days of CT examination.
  • Combined with multiple myeloma, urinary obstruction, aortic dissection
  • Can cause acute kidney injury disease;
  • Use of aminoglycosides and other nephrotoxic drugs 2 weeks before.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
CIN72hours

Compared with before examination, the increase of serum creatinine conforms to the diagnostic criteria of contrast induced nephropathy.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Guangdong provincial people's hospital

🇨🇳

Guanzhou, Guangdong, China

Guangdong provincial people's hospital
🇨🇳Guanzhou, Guangdong, China
huang jieleng, doctor
Contact

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.